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Summary
 Background Cancer incidence and its mortality depend on a number of factors, including 
age, socio-economic status and geographic situation, and its incidence is grow-
ing around the world [1]. Cancer incidence in Europe is now about 4000 pa-
tients per million per year and due to the ageing population a yearly increase of 
1–1.5% in cancer cases is estimated in the next two decades [2–4]. Most of the 
cancer treatments will include external beam radiotherapy or brachytherapy. 
Brachytherapy has increased its use as a radical or palliative treatment and be-
come more sophisticated with the spread of pulsed dose rate and high dose rate 
afterloading machines, and the use of new planning systems has additionally im-
proved quality of treatment [5–14]
 Aim The aim of the present study was to compare two countries (Poland and Spain) 
and to report the differences in the use of brachytherapy in these countries. For 
this reason, several characteristics related to brachytherapy were compared.
 Materials/Methods The data used were collected using a website questionnaire for the year 2002 
where every centre that participated in the survey could introduce, change or 
update the information requested. Hospitals included in the study were those 
that provided data on brachytherapy, because our objective was to compare the 
brachytherapy facilities between Poland and Spain.
 Results Data were available for 22 centres in Poland and 39 centres in Spain that provid-
ed brachytherapy in 2002. Spain having more centres that applied brachyther-
apy (1.0 centre per 1,000,000 inhabitants in Spain vs. 0.6 centre per 1,000,000 
inhabitants in Poland), the average number of brachytherapy patients per cen-
tre is lower in Spain than in Poland, 137 and 382 respectively. The 5 main tu-
mour sites treated with brachytherapy in Poland were: gynaecological (73.7%), 
bronchus (13.0%), breast (2.8%), prostate (2.4%) and head and neck (1.6%). 
In Spain they were: gynaecological (59.7%), breast (15.4%), prostate (12.8%), 
head and neck (4.2%) and bronchus (1.5%). Statistically signiﬁ cant differences 
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BACKGROUND
Cancer incidence and its mortality depend on a 
number of factors, including age, socio-economic 
status and geographic situation, and its incidence 
is growing around the world [1]. Cancer inci-
dence in Europe is now about 4000 patients per 
million per year and due to the ageing popula-
tion a yearly increase of 1–1.5% in cancer cases is 
estimated in the next two decades [2–4]. Most of 
the cancer treatments will include external beam 
radiotherapy or brachytherapy. Brachytherapy has 
increased its use as a radical or palliative treat-
ment and become more sophisticated with the 
spread of pulsed dose rate and high dose rate af-
terloading machines, and the use of new plan-
ning systems has additionally improved quality 
of treatment [5–14].
Patterns of Care for Brachytherapy in Europe 
(PCBE) was launched with the objective of col-
lecting detailed information on the brachyther-
apy pattern of care throughout the European 
area, allowing the study of this treatment meth-
od and monitoring of changes with time. These 
data were also considered crucial as a feasibility 
study in the framework of the ESTRO-QUARTS 
project (QUAntiﬁ cation of Radiation Therapy 
Infrastructure and Stafﬁ ng Needs, contract 
number GLG4-CT-2002-30583 with the EU).
The data collected from the PCBE project were 
used to compare two countries, Poland and Spain, 
in the application of brachytherapy in the year 
of 2002. It was agreed to compare these coun-
tries because they have a similar number of in-
habitants (38,654,164 in Poland and 40,016,081 
in Spain, year 2000) and population structure 
(Figure 1) and comparable area (312,685km2 
in Poland and 505,811km2 in Spain) [15]. Based 
on the data collected, a map for the distribution 
of radiotherapy facilities for Poland and Spain is 
shown in Figure 2. In both countries cancer inci-
dence is continuously growing except in Spanish 
women. As an example the changes in incidence 
in Spain and Poland since 1951 are presented 
(Figure 3) [16].
AIM
For these reasons, this paper reports the differ-
ences in the use of brachytherapy in these coun-
tries and several characteristics related to brach-
ytherapy are compared.
MATERIALS AND METHODS
The data used to compare Poland and Spain were 
based on the results obtained in the question-
naire completed for the PCBE project in 2002. 
The questionnaire was web-based because there 
were several reasons for thinking that it would 
be an easy way to achieve a large number of re-
sponses from the centres collaborating in the sur-
vey. The main reason was that the Internet allows 
easy access to the questionnaire and the manip-
ulation of the data. This was supported by the 
National Cancer Services Analysis Team, NHS, 
in the United Kingdom.
For every country that collaborated in the survey, 
a national coordinator was designated. He/she 
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were found in the number of gynaecological, bronchial and breast brachythera-
py patients between the countries.
 Conclusions Although both countries belong to the European Union, there were observed 
several differences in the use of brachytherapy. We also found some differences 
in the brachytherapy techniques used in prostate and head and neck cancers.
 Key words Poland • Spain • brachytherapy • patterns of care • European Union
 Full-text PDF: http:/www.rpor.pl/pdf.php?MAN=10078
 Word count: 1459
 Tables: 2
 Figures: 8
 References: 17
Original Paper Rep Pract Oncol Radiother, 2007; 12(1): 39-45
40
took several responsibilities: to coordinate the dis-
tribution of the questionnaires and to encourage 
compliance. Centres in each country were asked 
to submit data regarding brachytherapy services 
and activity during 1997 and 2002. There was also 
named a general coordinator who was responsi-
ble for ensuring the correct development of the 
process and to solve any issues that might arise.
We chose two similar countries (Spain and 
Poland) for the following reasons: similar number 
of inhabitants, population structure and pattern 
of cancer incidence. We compared these coun-
tries to report differences in the use of brach-
ytherapy and several characteristics related to 
brachytherapy.
The statistical analysis was performed using the 
t-test or Mann-Whitney test, depending on the 
distribution of the variables, in order to assess 
Figure 1. Population pyramid summary for Poland and Spain (2000 and 2050).
Figure 2. Distribution of radiotherapy facilities in Poland and 
Spain (2002).
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whether the means of the two countries were sta-
tistically different from each other. The
Kolmogorav-Smirnov test was applied to test for 
a normal distribution. A p value<0.05 was con-
sidered statistically signiﬁ cant for all procedures 
used. Also, the 95% conﬁ dence interval for each 
average was estimated, in order to have an accu-
rate idea of the variable. The SPSS (Statistical 
Package for the Social Sciences) package was 
used for the analysis.
RESULTS
The ﬁ nal results of PCBE [17] showed that 737 
of 1064 European radiotherapy centres (69.3%) 
responded to the questionnaire. Of these centres, 
450 (42%) conﬁ rmed that they provide brachy-
therapy treatments.
In the present study, there were 25 centres in 
Poland and 74 centres in Spain that applied ra-
diotherapy in 2002. The inclusion criteria were 
achieved for 25 centres in Poland (100%) and 
22 had brachytherapy (88%), whereas 72 centres 
in Spain achieved the inclusion criteria (97.3%) 
and only 39 centres provided brachytherapy 
(52.7%).
Figure 3. Age Standardised Rate (World) age [0–85+] (all 
cancers).
Figure 4. Age Standardised Rate (World) age [0–85+] in 
Poland.
Figure 5. Age Standardised Rate (World) age [0–85+] in Spain.
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Figure 6. Distribution of patients according to site implanted for 
the most common tumour sites.
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The average number of patients per centre treat-
ed with radiotherapy during the year 2002 was 
1802 (CI 95% 872-2733) in Poland and 1203 
(CI 95% 1013–1393) in Spain, but these differ-
ences were not statistically signiﬁ cant (p=0.986, 
Mann-Whitney). There were observed signiﬁ cant 
differences in the average number of patients per 
centre treated with brachytherapy: it was 382 (CI 
Poland Spain Europe
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Figure 7. Brachytherapy used in the most common sites treated (%).
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Figure 8. Number of shielded rooms, operating rooms, ongoing brachytherapy trials and educational programs.
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95% 231–533) in Poland and 137 (CI 95% 96-177) 
in Spain (p=0.001, Mann-Whitney). The centres 
with the largest number of patients in 2002 were, 
in Poland: Centrum Onkologii – Instytut im. Marii 
Skłodowskiej-Curie in Warsaw (1100), Centrum 
Onkologii – Instytut im. Marii Skłodowskiej-
Curie in Gliwice (1003), Wielkopolskie Centrum 
Onkologii im. Marii Skłodowskiej-Curie in 
Poznań (774), Regionalne Centrum Onkologii 
Szpital prof. F. Łukaszczyka in Bydgoszcz (724) 
and Wojewódzki Szpital Specjalistyczny im. M. 
Kopernika (623) in Łódź. In Spain they were: 
Institut Catala d’Oncologia (704), Instituto 
Oncológico de Guipuzcoa (318), Clinica 
Ruber Internacional (279), Centro Oncológico 
de Galicia (270) and Instituto Valenciano de 
Oncologia (257).
There has been observed an increase in the 
number of brachytherapy patients between 1997 
and 2002: 21.4% in Spain and 23.2% in Poland. 
A difference in the average increase of treated 
patients per centre with brachytherapy in com-
parison with the European area was also noted, 
where the average increase between 1997 and 
2002 was 10.2% [17]. On the other hand, Spain 
had 96.9% of brachytherapy procedures with cur-
ative intention and Poland 81.3%.
There were 252 radiation oncologists in Spain, 
57.1% involved in brachytherapy. In contrast, 
Poland had 219 radiation oncologists, 30.6%
countries. Finally it was observed than in Poland 
there were other rare sites treated, such as large 
vessels (endovascular brachytherapy), soft tissue 
sarcomas or brain tumours. In contrast Spain 
treated more patients with uveal melanoma by 
means of episcleral brachytherapy.
A higher use of HOR in Poland for prostate and 
head and neck cancers and less LOR than in 
Spain was observed. This can be explained by 
the fact that HOR equipment allows a signiﬁ -
cantly larger number of patients treated for the 
same costs compared to the traditional use of 
LOR in Spain.
Another variable that showed important variation 
between these two countries is access to research 
programmes and educational programmes, with 
a much higher percentage in Spain.
This study has some limitations. First of all, data 
were based on the individual reports from both 
countries and each centre, and although eve-
ry possible effort was made to make all the re-
ports consistent, variability in data quality may 
exist. Finally, this initial survey only allows for a 
descriptive analysis of activity. Interesting differ-
ences between the countries and regions have 
been identiﬁ ed
and future surveys to identify certain trends 
will be important. As patterns of disease change 
and health services across Europe develop it is 
to be expected that for example the high inci-
dence of gynaecological cancers in Poland will 
fall and that incidence of prostate cancer and 
demand for its treatment with brachytherapy 
will increase this indication, bringing the prac-
tice closer to harmonisation between the two 
countries.
Poland Spain Europe
N (%)
Oesophagus  183 (2.6)  23 (0.5)  767 (2.3)
Rectum  61 (0.9)  27 (0.5)  660 (2.0)
Intracoronary  29 (0.4)  117 (2.3)  565 (1.7)
Eye  2 (0.0)  70 (1.4)  500 (1.5)
Skin  66 (0.9)  62 (1.2)  446 (1.4)
Other  26 (0.4)  15 (0.3)  149 (0.5)
Large vessels  9 (0.1) –  86 (0.3)
Brain  81 (1.1)  1 (0.0)  83 (0.3)
Bladder – –  52 (0.2)
Soft tissue  3 (0.0) –  43 (0.1)
Total  460 (6.5)  315 (6.3)  3351 (10.2)
Table 1. Frequency of the least frequent tumour sites treated with 
brachytherapy (≤3%) in Europe.
* NPoland=7064, NSpain=4987, NEurope=32779.
Poland Spain
p*
Mean (CI 95%)
Gynaecological  236.6 (138.2,335.0)  76.3 (54.0,98.6) p<0.001
Prostate  7.6 (0.0,17.0)  16.3 (5.3,27.3) p=0.09 (ns)
Breast  9.0 (0.5,17.5)  19.7 (8.8,30.7) p=0.031
Bronchus  41.9 (12.5,71.2)  1.9 (0.5,3.4) p=0.016
Head and neck  5.1 (0.0,10.4)  5.3 (2.4,8.3) P=0.149 (ns)
Table 2. Average number of patients per centre and country for 
the most common tumour sites treated with brachytherapy.
* p<0.05, signifi cant; ns-not signifi cant; (Mann-Whitney).
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CONCLUSIONS
Although both countries belong to the European 
Union (EU), several differences in the use of 
brachytherapy were observed. Poland had fewer 
centres that provided radiotherapy or brachyther-
apy, but the average number of patients per cen-
tre treated with brachytherapy was higher than 
in Spain. In both countries an increase in the 
number of patients treated with this technique 
per centre was observed, and in both countries 
that increase was higher than 10.2%, observed 
in Europe in 2002 [17].
The workload of all the specialists who regular-
ly perform brachytherapy was estimated. There 
were no signiﬁ cant differences in radiation on-
cologists and technologists, but the workload 
for physicists was signiﬁ cantly higher in Poland 
than in Spain.
As far as the main tumour site is concerned, the 
countries had minor differences in the distribu-
tion in comparison with the European results. 
There were observed signiﬁ cant differences con-
sidering the average number of patients per cen-
tre for the most common tumour sites treated 
with brachytherapy. Poland had a larger average 
number of patients in gynaecological and bron-
chial tumour sites, whereas Spain had more pa-
tients treated with brachytherapy for breast can-
cer. For the less common tumour sites, Poland 
applied brachytherapy in a wide range of tumour 
sites and there were more patients treated in com-
parison with Spain.
The brachytherapy technique depends on the 
site to be treated, but depends also on the coun-
try. As an example, all prostate cancer patients 
in Poland were treated with HDR brachythera-
py, whereas in Spain permanent seeds (1–125) 
were mostly used.
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